{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:08:46Z","timestamp":1780945726479,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T00:00:00Z","timestamp":1617580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T00:00:00Z","timestamp":1617580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00403-021-02222-1","type":"journal-article","created":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T11:02:44Z","timestamp":1617620564000},"page":"223-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patient-reported outcome measures for patients with nail conditions: a systematic review of the psychometric evidence"],"prefix":"10.1007","volume":"314","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4298-4848","authenticated-orcid":false,"given":"Rakhshan","family":"Kamran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Algu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron F.","family":"Leveille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire R.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khizar","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,5]]},"reference":[{"issue":"4","key":"2222_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jaad.2018.03.062","volume":"80","author":"SR Lipner","year":"2019","unstructured":"Lipner SR, Scher RK (2019) Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol 80(4):835\u2013851","journal-title":"J Am Acad Dermatol"},{"key":"2222_CR2","doi-asserted-by":"crossref","unstructured":"Geizhals S, Lipner SR (2019) Review of onychocryptosis: epidemiology, pathogenesis, risk factors, diagnosis and treatment. Dermatol Online J 25(9):13030\/qt9985w2n0.","DOI":"10.5070\/D3259045583"},{"issue":"1","key":"2222_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","volume":"57","author":"MM Jiaravuthisan","year":"2007","unstructured":"Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY (2007) Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 57(1):1\u201327","journal-title":"J Am Acad Dermatol"},{"key":"2222_CR4","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/9781119142812.ch161","volume-title":"Harper\u2019s textbook of pediatric dermatology [internet]","author":"A Tosti","year":"2019","unstructured":"Tosti A, Piraccini BM (2019) Nail disorders. Harper\u2019s textbook of pediatric dermatology [internet]. John Wiley & Sons, Ltd, pp 2147\u20132158.https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/9781119142812.ch161 (cited 2020 May 1)"},{"key":"2222_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-323-54433-7.00009-X","volume-title":"Nail disorders [internet]","author":"A Tosti","year":"2019","unstructured":"Tosti A (2019) Chapter 9\u2014nail cosmetics: benefits and side effects. In: Tosti A (ed) Nail disorders [internet]. Elsevier, pp 69\u201373. http:\/\/www.sciencedirect.com\/science\/article\/pii\/B978032354433700009X(cited 2020 Jun 17)"},{"key":"2222_CR6","doi-asserted-by":"publisher","unstructured":"Stewart CR, Algu L, Kamran R, Leveille CF, Abid K, Rae C et al (2020) Impact of onychomycosis and treatment on patient reported quality of life outcomes: a systematic review. J Am Acad Dermatol.  https:\/\/doi.org\/10.1016\/j.jaad.2020.05.143","DOI":"10.1016\/j.jaad.2020.05.143"},{"key":"2222_CR7","first-page":"1","volume":"17","author":"CR Stewart","year":"2020","unstructured":"Stewart CR, Algu L, Kamran R, Leveille CF, Abid K, Rae C et al (2020) Patient satisfaction with treatment for onychocryptosis: a systematic review. SAD 17:1\u20138","journal-title":"SAD"},{"issue":"5","key":"2222_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2710.2009.01107.x","volume":"35","author":"J Thomas","year":"2010","unstructured":"Thomas J, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H, Sharpe C (2010) Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther 35(5):497\u2013519","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"2222_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.det.2014.12.001","volume":"33","author":"M Iorizzo","year":"2015","unstructured":"Iorizzo M (2015) Tips to treat the 5 most common nail disorders: brittle nails, onycholysis, paronychia, psoriasis, onychomycosis. Dermatol Clin 33(2):175\u2013183","journal-title":"Dermatol Clin"},{"key":"2222_CR10","unstructured":"US Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. Available at https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm193282.pdf. Accessed 1 May 2020."},{"issue":"8","key":"2222_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E et al (2011) Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2\u2013assessing respondent understanding. Value Health 14(8):978\u2013988","journal-title":"Value Health"},{"issue":"9912","key":"2222_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(13)62227-8","volume":"383","author":"JPA Ioannidis","year":"2014","unstructured":"Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D et al (2014) Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383(9912):166\u2013175","journal-title":"Lancet"},{"issue":"7","key":"2222_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL et al (2010) The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 63(7):737\u2013745","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2222_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","volume":"19","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL et al (2010) The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 19(4):539\u2013549","journal-title":"Qual Life Res"},{"issue":"6","key":"2222_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jval.2015.08.006","volume":"18","author":"MK Walton","year":"2015","unstructured":"Walton MK, Powers JH, Hobart J, Patrick DL, Marquis P, Vamvakas S et al (2015) Clinical outcome assessments: conceptual foundation-report of the ISPOR clinical outcomes assessment\u2014emerging good practices for outcomes research task force. Value Health 18(6):741\u2013752","journal-title":"Value Health"},{"issue":"9","key":"2222_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1741-7015-9-86","volume":"14","author":"SP McKenna","year":"2011","unstructured":"McKenna SP (2011) Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med 14(9):86","journal-title":"BMC Med"},{"issue":"5","key":"2222_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","volume":"27","author":"LB Mokkink","year":"2018","unstructured":"Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM et al (2018) COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res 27(5):1171\u20131179","journal-title":"Qual Life Res"},{"issue":"3","key":"2222_CR18","first-page":"144","volume":"3","author":"J Wang","year":"2017","unstructured":"Wang J, Wiznia LE, Rieder EA (2017) Patient-reported outcomes in onychomycosis: a review of psychometrically evaluated instruments in assessing treatment effectiveness. SAD 3(3):144\u2013155","journal-title":"SAD"},{"issue":"4","key":"2222_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11136-011-9960-1","volume":"21","author":"CB Terwee","year":"2012","unstructured":"Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW (2012) Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 21(4):651\u2013657","journal-title":"Qual Life Res"},{"key":"2222_CR20","unstructured":"Terwee CB, Prinsen CAC, Chiarotto A, de Vet HCW, Bouster LM, Alonso J, et al. (2018) COSMIN methodology for assessing the content validity of PROMs user manual. COSMIN Steering Commitee, Amsterdam, The Netherlands. Available from https:\/\/www.cosmin.nl\/wp-content\/uploads\/COSMIN-methodology-for-content-validity-user-manual-v1.pdf"},{"key":"2222_CR21","doi-asserted-by":"crossref","unstructured":"Mokkink LB, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, de Vet HCW et al. (2018) COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs) user manual. COSMIN Steering Commitee, Amsterdam, The Netherlands. Available from https:\/\/www.cosmin.nl\/wp-content\/uploads\/COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018.pdf","DOI":"10.1007\/s11136-018-1798-3"},{"key":"2222_CR22","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2700 https:\/\/www.bmj.com\/content\/339\/bmj.b2535","DOI":"10.1136\/bmj.b2535"},{"issue":"3","key":"2222_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/bjd.12664","volume":"170","author":"M Augustin","year":"2014","unstructured":"Augustin M, Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G et al (2014) Nail assessment in psoriasis and psoriatic arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. Br J Dermatol 170(3):591\u2013598","journal-title":"Br J Dermatol"},{"issue":"8","key":"2222_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00403-009-0928-8","volume":"301","author":"M Augustin","year":"2009","unstructured":"Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Sch\u00e4fer I et al (2009) The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 301(8):561\u2013571","journal-title":"Arch Dermatol Res"},{"issue":"2 Pt 1","key":"2222_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","volume":"41","author":"LA Drake","year":"1999","unstructured":"Drake LA, Patrick DL, Fleckman P, Andr J, Baran R, Haneke E et al (1999) The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 41(2 Pt 1):189\u2013196","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2222_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00449429","volume":"2","author":"DP Lubeck","year":"1993","unstructured":"Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J (1993) Quality of life of persons with onychomycosis. Qual Life Res 2(5):341\u2013348","journal-title":"Qual Life Res"},{"issue":"1\u20132","key":"2222_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1026429012353","volume":"8","author":"DP Lubeck","year":"1999","unstructured":"Lubeck DP, Gause D, Schein JR, Prebil LE, Potter LP (1999) A health-related quality of life measure for use in patients with onychomycosis: a validation study. Qual Life Res 8(1\u20132):121\u2013129","journal-title":"Qual Life Res"},{"issue":"5 Pt 3","key":"2222_CR28","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1016\/S0190-9622(98)70487-6","volume":"38","author":"DP Lubeck","year":"1998","unstructured":"Lubeck DP (1998) Measuring health-related quality of life in onychomycosis. J Am Acad Dermatol 38(5 Pt 3):S64-68","journal-title":"J Am Acad Dermatol"},{"key":"2222_CR29","volume-title":"Measuring functioning and well-being: the medical outcomes study approach","author":"AL Stewart","year":"1992","unstructured":"Stewart AL, Ware JE (1992) Measuring functioning and well-being: the medical outcomes study approach. Duke University Press"},{"issue":"11","key":"2222_CR30","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","volume":"51","author":"JE Ware","year":"1998","unstructured":"Ware JE, Gandek B (1998) Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol 51(11):903\u2013912","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2222_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1468-3083.2009.03344.x","volume":"24","author":"JP Ortonne","year":"2010","unstructured":"Ortonne JP, Baran R, Corvest M, Schmitt C, Voisard JJ, Taieb C (2010) Development and validation of nail psoriasis quality of life scale (NPQ10). J Eur Acad Dermatol Venereol 24(1):22\u201327","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2222_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1023\/A:1008986826756","volume":"9","author":"RR Turner","year":"2000","unstructured":"Turner RR, Testa MA (2000) Measuring the impact of onychomycosis on patient quality of life. Qual Life Res 9(1):39\u201353","journal-title":"Qual Life Res"},{"issue":"4","key":"2222_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1477-7525-4-50","volume":"15","author":"LP Potter","year":"2006","unstructured":"Potter LP, Mathias SD, Raut M, Kianifard F, Tavakkol A (2006) The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis. Health Qual Life Outcomes 15(4):50","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"2222_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1365-4632.2007.03362.x","volume":"46","author":"EM Warshaw","year":"2007","unstructured":"Warshaw EM, Foster JK, Cham PMH, Grill JP, Chen SC (2007) NailQoL: a quality-of-life instrument for onychomycosis. Int J Dermatol 46(12):1279\u20131286","journal-title":"Int J Dermatol"},{"issue":"11","key":"2222_CR35","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.ijnurstu.2015.07.002","volume":"52","author":"DF Polit","year":"2015","unstructured":"Polit DF (2015) Assessing measurement in health: beyond reliability and validity. Int J Nurs Stud 52(11):1746\u20131753","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"2222_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2288-10-22","volume":"10","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL et al (2010) The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 10(1):22","journal-title":"BMC Med Res Methodol"},{"key":"2222_CR37","first-page":"616","volume-title":"Encyclopedia of research design [internet]","author":"KA Barchard","year":"2010","unstructured":"Barchard KA (2010) Internal consistency reliability. Encyclopedia of research design [internet]. SAGE Publications, Inc, Thousand Oaks, pp 616\u2013619. http:\/\/sk.sagepub.com\/reference\/researchdesign\/n191.xml (cited 2020 Jun 23)"},{"key":"2222_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2288-11-152","volume":"11","author":"F Angst","year":"2011","unstructured":"Angst F (2011) The new COSMIN guidelines confront traditional concepts of responsiveness. BMC Med Res Methodol 11:152. https:\/\/doi.org\/10.1186\/1471-2288-11-152 (Mokkink LB, Terwee CB, Knol DL, de Vet HCW 2011. The new COSMIN guidelines regarding responsiveness. Author\u2019s response. BMC Med Res Methodol;11:152)","journal-title":"BMC Med Res Methodol"},{"issue":"122","key":"2222_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jclinepi.2020.01.019","volume":"1","author":"N Santesso","year":"2020","unstructured":"Santesso N, Barbara AM, Kamran R, Akkinepally S, Cairney J, Akl EA et al (2020) Conclusions from surveys may not consider important biases: a systematic survey of surveys. J Clin Epidemiol 1(122):108\u2013114","journal-title":"J Clin Epidemiol"},{"key":"2222_CR40","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1007\/s11136-018-1982-5","volume":"27","author":"LA Williams","year":"2018","unstructured":"Williams LA, Whisenant MS, Mendoza TR et al (2018) Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson symptom inventory for malignant pleural mesothelioma (MDASI-MPM). Qual Life Res 27:3229\u20133241. https:\/\/doi.org\/10.1007\/s11136-018-1982-5","journal-title":"Qual Life Res"},{"issue":"1","key":"2222_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s41687-019-0130-5","volume":"3","author":"AM Stover","year":"2019","unstructured":"Stover AM, McLeod LD, Langer MM, Chen WH, Reeve BB (2019) State of the psychometric methods: patient-reported outcome measure development and refinement using item response theory. J Patient Rep Outcomes 3(1):50. https:\/\/doi.org\/10.1186\/s41687-019-0130-5","journal-title":"J Patient Rep Outcomes"},{"key":"2222_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2288-6-2","volume":"6","author":"LB Mokkink","year":"2006","unstructured":"Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, Bouter LM, de Vet HCW (2006) Protocol of the COSMIN study: consensus-based standards for the selection of health measurement instruments. BMC Med Res Methodol 6:2","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"2222_CR43","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","volume":"27","author":"CAC Prinsen","year":"2018","unstructured":"Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, Terwee CB (2018) COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res 27(5):1147\u20131157. https:\/\/doi.org\/10.1007\/s11136-018-1798-3","journal-title":"Qual Life Res"},{"issue":"5","key":"2222_CR44","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","volume":"27","author":"CB Terwee","year":"2018","unstructured":"Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, Bouter LM, de Vet HCW, Mokkink LB (2018) COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res 27(5):1159\u20131170. https:\/\/doi.org\/10.1007\/s11136-018-1829-0","journal-title":"Qual Life Res"},{"issue":"5","key":"2222_CR45","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","volume":"27","author":"LB Mokkink","year":"2018","unstructured":"Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, Terwee CB (2018) COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res 27(5):1171\u20131179. https:\/\/doi.org\/10.1007\/s11136-017-1765-4","journal-title":"Qual Life Res"},{"issue":"8","key":"2222_CR46","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","volume":"12","author":"M Rothman","year":"2009","unstructured":"Rothman M, Burke L, Erickson P et al (2009) Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value Health 12(8):1075\u20131083","journal-title":"Value Health"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-021-02222-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T12:05:05Z","timestamp":1647086705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-021-02222-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2222"],"URL":"https:\/\/doi.org\/10.1007\/s00403-021-02222-1","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,5]]},"assertion":[{"value":"27 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest or competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not required as this is a systematic review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}